What is the current stock price of Rafael Holdings, Inc. (RFL)?

As of the latest market data, Rafael Holdings, Inc. (RFL) is trading at $1.26. The stock has seen a loss of -3.82% today.

Does Rafael Holdings, Inc. (RFL) pay a dividend?

Based on current data, Rafael Holdings, Inc. does not have a confirmed active dividend policy.

What is the market cap of Rafael Holdings, Inc.?

The current market capitalization of Rafael Holdings, Inc. (RFL) is approximately unavailable.

RFL

Rafael Holdings, Inc.·Real Estate

1.26

3.817%(−0.05)

Market Closed

1.38

9.524%(+0.12)

After Hours

Last Updated: — ET

52W L: $1.1252W H: $3.19

RFL NEWS

defenseworld.net

3d ago

Critical Comparison: Elite Pharmaceuticals (OTCMKTS:ELTP) versus Rafael (NYSE:RFL)

Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) and Rafael (NYSE: RFL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership. Profitability This table compares Elite Pharmaceuticals and Rafael's

prnewswire.com

Apr 1

Keurig Dr Pepper Acquires JDE Peet's and Announces Rafael Oliveira as CEO of Future Global Coffee Co.

Transaction creates global coffee powerhouse Oliveira will continue as JDE Peet's CEO and joins KDP to lead combined coffee business This is a joint press release by Keurig Dr Pepper Inc., Kodiak BidCo B.V. and JDE Peet's N.V.

globenewswire.com

Apr 1

Keurig Dr Pepper Acquires JDE Peet's and Announces Rafael Oliveira as CEO of Future Global Coffee Co.

globenewswire.com

Mar 16

Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results

NEWARK, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the second quarter fiscal year 2026 ended January 31, 2026.

globenewswire.com

Feb 23

T3 Defense Brings in Former Rafael and Avnon Leadership to Lead Business Operations

Appointments add decades of defense, security, and international program experience to T3 Defense's executive team Appointments add decades of defense, security, and international program experience to T3 Defense's executive team

defenseworld.net

Feb 20

Analyzing Rafael (NYSE:RFL) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP)

Rafael (NYSE: RFL - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation. Profitability This table compares Rafael and 60

Company Profile

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

Sector

Real Estate

Industry

Real Estate - Services

Employees

IPO Date

2018-03-27

Beta

0.51

Websitewww.rafaelholdings.com↗